Get started
Author

Pascal Irrgang

Observed name: Irrgang, Pascal
ORCID: 0000-0003-2829-6096
Observed ORCID: 0000-0003-2829-6096
OpenAlex ID: A5046989441
Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination
2022 · Pascal Irrgang, Juliane Gerling, et al. · Science Immunology · 265
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
2021 · Dennis Lapuente, Jana Fuchs, et al. · Nature Communications · 209
PDF
Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2
2021 · Matthias Tenbusch, Sofie Schumacher, et al. · The Lancet Infectious Diseases · 115
PDF
XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors
2023 · Lukas Heger, Lukas Hatscher, et al. · Proceedings of the National Academy of Sciences · 53
Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®)
2021 · Jürgen Held, Jan Esse, et al. · Vaccines · 38
PDF
Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2
2020 · Dennis Lapuente, Clara Maier, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 37
PDF
Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2
2022 · Emanuel Vogel, Katharina Kocher, et al. · EBioMedicine · 31
PDF
Mucosal immunization with an adenoviral vector vaccine confers superior protection against RSV compared to natural immunity
2022 · Clara Maier, Jana Fuchs, et al. · Frontiers in Immunology · 25
PDF
Adaptive immune responses are larger and functionally preserved in a hypervaccinated individual
2024 · Katharina Kocher, Carolin Moosmann, et al. · The Lancet Infectious Diseases · 19
Mucosal tumor vaccination delivering endogenous tumor antigens protects against pulmonary breast cancer metastases
2024 · Friederike Oltmanns, Ana Vieira Antão, et al. · Journal for ImmunoTherapy of Cancer · 17
PDF
Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy
2022 · Hannah Reimann, Anita N. Kremer, et al. · Blood Advances · 15
Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections
2021 · Timo Huber, Philipp Steininger, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 12
PDF
Inflammatory conditions shape phenotypic and functional characteristics of lung-resident memory T cells in mice
2025 · Anna Schmidt, Jana Fuchs, et al. · Nature Communications · 9
PDF
Filling two needs with one deed: a combinatory mucosal vaccine against influenza A virus and respiratory syncytial virus
2024 · Ana Vieira Antão, Friederike Oltmanns, et al. · Frontiers in Immunology · 7
Evaluation of adenoviral vector Ad19a encoding RSV-F as novel vaccine against respiratory syncytial virus
2024 · Jana Fuchs, Julian Hübner, et al. · npj Vaccines · 6
PDF
Orally bioavailable RORγ/DHODH dual host-targeting small molecules with broad-spectrum antiviral activity
2024 · Alexandra Herrmann, Christian Gege, et al. · Antiviral Research · 6
Adenoviral vector oropharyngeal spray immunization elicits mucosal immunity and protects against heterologous SARS-CoV-2 infection
2025 · Gerrit Koopman, Petra Mooij, et al. · npj Vaccines · 3
PDF
Adenoviral vector vaccines are effective mucosal booster modalities to elevate systemic and establish mucosal immunity against SARS-CoV-2
2023 · Dennis Lapuente, Vera Viherlehto, et al. · The Journal of Immunology · 2
PDF
Mucosal vaccination with an adenoviral vector vaccine protects against pulmonary breast cancer metastasis by robust induction of tissue-resident memory T-cells in the lung
2023 · Friederike Elise Oltmanns, Ana Vieira Antão, et al. · The Journal of Immunology · 1
PDF
A Confirmatory, Dual Center Nonhuman Primate Study on the Efficacy of Novel Oropharyngeal Spray Immunization With an Adenoviral Vector Vaccine Against RSV —Important Lessons Learned
2026 · Matthias Tenbusch, Gerrit Koopman, et al. · Journal of Medical Primatology
PDF
DHODH Inhibitors Based on the Vidofludimus Scaffold Containing Carboxylic Acid Bioisosteres Exert a Superior Broad-Spectrum Antiviral Activity
2026 · Alexandra Herrmann, Friedrich Hahn, et al. · Journal of Medicinal Chemistry
Simultaneous quantification of anti-Spike IgG subclasses against various SARS-CoV-2 variants using a multiplex serological assay
2026 · Marie L. Bischof, Pascal Irrgang, et al. · Medical Microbiology and Immunology
PDF
Live attenuated vaccination protects aged chimeric ACE2 mice from severe SARS-CoV-2 pathogenicity in vivo
2026 · Alina Russ, Vera Viherlehto, et al. · PLoS Pathogens
PDF
A confirmatory, dual-centric non-human primate study on the efficacy of novel oropharyngeal spray immunization with an adenoviral vector vaccine against RSV – Important lessons learned
2026 · Matthias Tenbusch, Gerrit Koopman, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Inflammatory conditions shape phenotypic and functional characteristics of lung-resident memory T cells
2023 · Anna Schmidt, Jana Fuchs, et al. · The Journal of Immunology
PDF
Works count: 28
Citation count: 870
H-index: 12
I10-index: 12
Year
Topic
Type